Wegmans opens prescription services to the family pet
ROCHESTER, N.Y. — Wegmans has expanded its pharmaceutical services to include the family pet, according a recent blog.
The supermarket pharmacy is advertising the service as a cheaper alternative to the prices paid at the veterinarian for the same canine/feline pharmaceuticals. Using Heartgard Plus Chew as an example, Wegmans noted that the common vet pricing is $50.20. Wegmans sells the same prescription for $44.99 and a generic equivalent for $19.99.
"Most common are drugs for heartworm, antibiotics and anti-inflammatory drugs, followed by those for anxiety, diabetes, diuretics, ear, heart, hormones, intestinal parasites, thyroid, vitamin/supplements, digestion issues and obesity," Mary Ellen Burris, Wegmans SVP consumer affairs, wrote in her blog. Wegmans has posted a list of the most common prescriptions on its website.
In addition to fielding pet prescriptions, Wegmans also allows patients to register their pets as dependents online, where they’ll be able to check status of an order or see which prescriptions are on automated refill, for example.
"When your pet is sick, you’re already anxious. With the potential savings on these medications, you’ve got one less thing to worry about," Burris concluded.
Teva launches generic Xeloda tablets
JERUSALEM — Teva Pharmaceutical Industries will launch the generic version of Xeloda (capecitabine) tablets, 150 mg and 500 mg, in the United States. The drug is used to treat cancers that have metastasized.
Xeloda tablets, 150 mg and 500 mg had annual sales in the United States of approximately $754 million as of December 2013, according to IMS.
MPS&A’s pharmacy management system EnterpriseRx earns industry accolades
LIVONIA, Mich. — McKesson Pharmacy Systems & Automation on Friday announced that EnterpriseRx — its cloud-based, centrally hosted pharmacy management system — earned top honors as a Category Leader in the 2013 Best in KLAS: Software and Services report. KLAS, an independent healthcare research organization, reserves the Category Leader designation for vendors that lead select market segments with software solutions designed to help healthcare professionals provide better care for their patients.
“We are proud to earn KLAS’s recognition for the outstanding technology that EnterpriseRx offers the health system market,” stated Emilie Ray, VP and general manager, outpatient, MPS&A. “We believe our pharmacy management system’s strong ranking in this industry is a reflection of our commitment to provide world-class pharmacy solutions to pharmacists, physicians and patients.”
EnterpriseRx is designed to allow pharmacists to run a patient-centered business and to make a pronounced difference in the way that pharmacies are traditionally run. The system increases operational efficiencies behind the counter so that pharmacists can spend more time on clinical programs such as adherence, medication therapy management and distribution of specialty medications.
“EnterpriseRx has set its self apart in operational efficiency and support of clinical programs, but our next focus is on connectivity between providers throughout the health system,” said Nathan Mott, president MPS&A. “With the backing of McKesson and our involvement in the CommonWell Health Alliance, we are looking forward to being at the forefront of an initiative that connects pharmacy to the continuum of care.”